These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
117 related items for PubMed ID: 10452296
21. [Multicenter study of darbepoetin alfa in the treatment of anemia secondary to chronic renal insufficiency on dialysis]. Martínez Castelao A, Reyes A, Valdés F, Otero A, López de Novales E, Pallardó L, Tabernero JM, Hernández Jaras J, Lladós F. Nefrologia; 2003; 23(2):114-24. PubMed ID: 12778875 [Abstract] [Full Text] [Related]
22. Infrequent dosing of subcutaneous erythropoietin for the treatment of anemia in patients on CAPD. Bunke M, Bartlett DK, Brier ME, Golper TA. Adv Perit Dial; 1993; 9():331-5. PubMed ID: 8105957 [Abstract] [Full Text] [Related]
23. Intravenous versus subcutaneous dosing of epoetin alfa in hemodialysis patients. Paganini EP, Eschbach JW, Lazarus JM, Van Stone JC, Gimenez LF, Graber SE, Egrie JC, Okamoto DM, Goodkin DA. Am J Kidney Dis; 1995 Aug; 26(2):331-40. PubMed ID: 7645538 [Abstract] [Full Text] [Related]
24. [Treatment of renal anemia with intravenous erythropoietin in patients in the program of continuous ambulatory peritoneal dialysis]. Zelichowski G, Lubas A, Sienkiewicz M, Janusz E, Wańkowicz Z. Pol Merkur Lekarski; 2008 Apr; 24(142):312-5. PubMed ID: 18634362 [Abstract] [Full Text] [Related]
25. [Single weekly dose of recombinant erythropoietin in children with chronic renal insufficiency]. Guízar JM, Gutiérrez MJ, Sánchez G, Kornhauser C. Rev Invest Clin; 1996 Apr; 48(3):173-7. PubMed ID: 8966377 [Abstract] [Full Text] [Related]
26. Pain at the injection site of subcutaneously administered erythropoietin in maintenance hemodialysis patients: a comparison of two brands of erythropoietin. Veys N, Vanholder R, Lameire N. Am J Nephrol; 1992 Apr; 12(1-2):68-72. PubMed ID: 1415368 [Abstract] [Full Text] [Related]
30. The use of subcutaneous erythropoietin in CAPD patients. Piraino B, Johnston JR. Clin Nephrol; 1990 Apr; 33(4):200-2. PubMed ID: 2350907 [Abstract] [Full Text] [Related]
33. Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients. Cody J, Daly C, Campbell M, Donaldson C, Grant A, Khan I, Vale L, Wallace S, MacLeod A. Cochrane Database Syst Rev; 2002 Apr; (4):CD003895. PubMed ID: 12519614 [Abstract] [Full Text] [Related]
36. [Maintenance therapy on the anemia in continuous ambulatory peritoneal dialysis (CAPD) patients using subcutaneous administration of recombinant human erythropoietin fortnightly--a multicenter trial]. Kubota M, Kawaguchi Y, Nomoto Y, Tsuchida H, Nihei H, Kubo K, Omori Y, Babazono T, Ogura Y, Hara S. Nihon Jinzo Gakkai Shi; 1993 Sep; 35(9):1081-90. PubMed ID: 8230819 [Abstract] [Full Text] [Related]
40. The efficacy of once weekly compared with two or three times weekly subcutaneous epoetin beta: results from a randomized controlled multicentre trial. Swedish Study Group. Weiss LG, Clyne N, Divino Fihlho J, Frisenette-Fich C, Kurkus J, Svensson B. Nephrol Dial Transplant; 2000 Dec; 15(12):2014-9. PubMed ID: 11096148 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]